Drugs

Feb 19, 2024, 17:05

Patrick Hwu: The FDA approved a groundbreaking treatment called TIL Therapy for advanced melanoma

Patrick Hwu, President and CEO at Moffitt Cancer Center, shared on LinkedIn:

“Today, the FDA approved a groundbreaking treatment called TIL Therapy for advanced melanoma. We are grateful Moffitt Cancer Center could play an integral role in the development of this lifesaving therapy.

Thank you to Amod Sarnaik, Shari Pilon-Thomas, Dr. James Mule’, their teams and so many others for their important work on TIL Therapy through the years.

It is our hope that future iterations of TIL will be important for lung cancer, colon cancer, head and neck cancer, bladder cancer, and many other cancer types.

Read the story from NBC News.”

Source: Patrick Hwu/LinkedIn

advanced melanoma Amod Sarnaik bladder cancer cancer Colon cancer FDA approved Head and Neck Cancer James Mule' Lung cancer Moffit Cancer Centre NBC News OncoDaily Oncology Patrick Hwu Shari Pilon-Thomas TIL Therapy

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage